Danaher Corporation (NYSE:DHR) Shares Sold by Private Capital Advisors Inc.

Private Capital Advisors Inc. decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 2.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 56,353 shares of the conglomerate's stock after selling 1,671 shares during the quarter. Danaher makes up about 1.4% of Private Capital Advisors Inc.'s holdings, making the stock its 23rd largest position. Private Capital Advisors Inc.'s holdings in Danaher were worth $11,552,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in DHR. GHP Investment Advisors Inc. boosted its holdings in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter valued at approximately $27,000. Sierra Ocean LLC lifted its position in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after acquiring an additional 76 shares during the period. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher during the 1st quarter valued at approximately $31,000. Finally, Hurley Capital LLC acquired a new stake in shares of Danaher during the 4th quarter valued at approximately $34,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research reports. Wells Fargo & Company reduced their price target on shares of Danaher from $240.00 to $210.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 23rd. Barclays reiterated an "overweight" rating and set a $225.00 price target (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. The Goldman Sachs Group cut their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Evercore ISI cut their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th. Finally, Bank of America cut their price objective on Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Three research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $248.43.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president directly owned 15,179 shares of the company's stock, valued at $3,005,442. This represents a 51.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman directly owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.20% of the company's stock.

Danaher Stock Up 0.3%

Danaher stock traded up $0.54 during trading on Wednesday, reaching $193.40. 2,649,364 shares of the company's stock were exchanged, compared to its average volume of 3,516,992. The company's 50-day moving average is $196.11 and its two-hundred day moving average is $205.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $281.70. The firm has a market cap of $138.41 billion, a price-to-earnings ratio of 37.55, a PEG ratio of 2.78 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The firm had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.66%. Danaher's payout ratio is currently 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.